September's Latest News, Upcoming Events, NOFOs, Grant Updates, and Reminders
POSTED: 9/24/2025
SOURCE: DCP Updates

In this issue we present: Preliminary Results of the ULACNet-201 Trial, La Lucha Sigue: The Fight Continues, and ULACNet Studies Have Cumulatively Screened Over 3,100 People at Increased Risk of HPV-Related Cancers
POSTED: 9/15/2025
SOURCE: DCP News
Latest News; Grant Updates; Upcoming Event; Forecast to Publish Notice of Funding Opportunities (NOFOs); Reminders
POSTED: 8/14/2025
SOURCE: DCP Updates
Latest News, Upcoming Event, Reminder
POSTED: 7/22/2025
SOURCE: DCP Updates
Latest News; Upcoming Events; Reminders
POSTED: 5/28/2025
SOURCE: DCP Updates

I-SCORE 2025; Staff Highlight; Partner Highlight; DMACC Updates; Research Funding Opportunities; Active and DCP-Approved Studies; Upcoming Events; How to Reach Us
POSTED: 5/27/2025
SOURCE: CP-CTNet DMACC Website

More than thirty years ago, NCI announced an ambitious cancer screening trial to find answers about the utility of cancer screening tests in preventing deaths from four types of cancer. This year, the Prostate, Lung,… Learn more
POSTED: 5/27/2025
SOURCE: Cancer Prevention Science Blog
Latest News, Upcoming Events, Notice of Funding Opportunities, Reminders
POSTED: 5/13/2025
SOURCE: DCP Updates
Upcoming Events; Funding Opportunities
POSTED: 5/6/2025
SOURCE: DCP Updates

Consider attending these AACR sessions virtually or in-person to learn the latest from DCP.
POSTED: 4/25/2025
SOURCE: DCP Meetings and Events
Upcoming Events; Latest Videos
POSTED: 4/8/2025
SOURCE: DCP Updates
Latest News
POSTED: 3/4/2025
SOURCE: DCP Updates
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The study, funded by the National… Learn more
POSTED: 1/15/2025
SOURCE: ECOG-ACRIN Press Release
Latest News, Upcoming Events, Notice of Funding Opportunities (NOFOs): Cancer Risk and Prevention
POSTED: 1/14/2025
SOURCE: DCP Updates

Over the last five decades, the number of deaths from many cancer types has dropped substantially in the U.S. A range of factors have played a role in this decrease. These include better treatments, prevention efforts such… Learn more
POSTED: 1/14/2025
SOURCE: NIH Research Matters

The National Cancer Institute (NCI) has selected two assays to be included in the Vanguard Study: Avantect® Multi-Cancer Detection Test by ClearNote Health and Shield™ Multi-Cancer Detection Test by Guardant Health.
POSTED: 1/7/2025
SOURCE: DCP News